scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.LEUKRES.2006.02.004 |
P698 | PubMed publication ID | 16533526 |
P2093 | author name string | Tomoko Yamamoto | |
Hitoshi Kiyoi | |||
Tomoki Naoe | |||
Hiroshi Yagasaki | |||
Juan Liang | |||
Kazuko Kudo | |||
Yoshiro Kamachi | |||
Yinyan Xu | |||
Mariko Isomura | |||
Seiji Kojma | |||
P433 | issue | 9 | |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | 1085-1089 | |
P577 | publication date | 2006-03-14 | |
P1433 | published in | Leukemia Research | Q15716445 |
P1476 | title | PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia | |
P478 | volume | 30 |
Q79777437 | A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome |
Q36905741 | A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma |
Q41535044 | Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia. |
Q34143049 | Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia |
Q89475164 | CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations |
Q46220127 | Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia |
Q84713544 | Cytogenetics and molecular genetics of acute lymphoblastic leukemia |
Q33778374 | FLT3 Internal Tandem Duplication and D835 Mutations in Patients with Acute Lymphoblastic Leukemia and its Clinical Significance |
Q46944335 | FLT3 mutations in a 10 year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns |
Q33704528 | FLT3mutation incidence and timing of origin in a population case series of pediatric leukemia |
Q41407670 | Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival |
Q54406965 | Impact of mutations in FLT3, PTPN11 and RAS genes on the overall survival of pediatric B cell precursor acute lymphoblastic leukemia in Brazil. |
Q34503441 | Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis |
Q37142140 | Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome |
Q35220417 | Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group |
Q36290242 | Molecular genetics of B-precursor acute lymphoblastic leukemia |
Q51753853 | Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution. |
Q47884832 | Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia |
Q46971359 | Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. |
Q33722741 | Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia |
Q35101627 | Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis |
Q103028965 | RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia |
Q38227885 | Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting |
Q36989335 | Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2. |
Q38460308 | The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia. |
Q37732956 | The tyrosine phosphatase Shp2 in development and cancer |
Q33401984 | Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia |
Search more.